AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Oncopeptides

Major Shareholding Notification Jun 11, 2024

3091_iss_2024-06-11_54a1ded8-415e-40d4-8717-2d62d8a871a4.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

Issuer Oncopeptides AB

Holder

Nordnet AB (publ)

Instrument

Instrument Aktie SE0009414576
Before the transaction
Shares Data not given*
Voting rights Data not given*
Transaction
Reason for major shareholding notification Sell
Date 10/06/2024
Limit for number of shares 5 %
After the transaction
Quantity
Shares 10,720,323
Directly held voting rights 0
Indirectly held voting rights 10,720,323
Percentage
Directly held shares 4.98188 %
Directly held voting rights 0 %
Indirectly held voting rights 5.0701 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 5.0701 % 10,720,323
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 5.0701 % 10,720,323
Chain
of
controlling
companies
Voting rights % Voting rights Company
10,403,564 4.92029
Nordnet Pensionsförsäkring AB
316,759
0.1498
Nordnet Livsforsikring AS
Group
total
holdings
Voting rights
10,720,323
Percentage of voting rights 5.0701
Published
11/06/2024 14:06
Contact
Name
Felix Mandoki
Phone
+46766110734 Email [email protected]
*Source of information has chosen not to submit the data

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25

Talk to a Data Expert

Have a question? We'll get back to you promptly.